{
    "clinical_study": {
        "@rank": "36852", 
        "arm_group": {
            "arm_group_label": "VISION5 Product", 
            "arm_group_type": "Experimental", 
            "description": "VISION5 Product in both eyes"
        }, 
        "brief_summary": {
            "textblock": "The objective of this Phase 1 study is to evaluate the VISION5 Product's safety and\n      efficacy."
        }, 
        "brief_title": "A Study of the VISION5 Product in Patients With Glaucoma or Ocular Hypertension", 
        "completion_date": {
            "#text": "June 2014", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Ocular Hypertension", 
            "Primary Open Angle Glaucoma"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Glaucoma", 
                "Glaucoma, Open-Angle", 
                "Hypertension", 
                "Ocular Hypertension"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Written informed consent\n\n          -  Primary open-angle glaucoma or ocular hypertension in both eyes\n\n          -  Best-corrected distance vision of 20/100 or better\n\n          -  Stable visual field\n\n        Exclusion Criteria:\n\n          -  Cup-to-disc ratio greater than 0.8\n\n          -  Laser surgery for glaucoma/ocular hypertension on one or both eyes within the last 12\n             months\n\n          -  Corneal refractive surgery within prior 6 months\n\n          -  Past history of any incisional surgery for glaucoma at any time\n\n          -  Corneal abnormalities that would interfere with tonometry readings\n\n          -  Current participation in an investigational drug or device study or participation in\n             such a study within 30 days of screening"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "20", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "September 10, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01943721", 
            "org_study_id": "ForSight VISION5 Study 504"
        }, 
        "intervention": {
            "arm_group_label": "VISION5 Product", 
            "intervention_name": "VISION5 Product", 
            "intervention_type": "Drug"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "December 2, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Contact ForSight VISION5 for Trial Locations", 
                    "country": "Latvia"
                }, 
                "name": "Contact ForSight VISION5 for Trial Locations"
            }, 
            "investigator": {
                "last_name": "Please Contact ForSight VISION5 for Trial Locations", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Latvia"
        }, 
        "number_of_arms": "1", 
        "official_title": "A Study of the VISION5 Product in Patients With Glaucoma or Ocular Hypertension", 
        "overall_contact": {
            "email": "gwalker@forsightv5.com", 
            "last_name": "Gary Walker, PhD", 
            "phone": "650-325-2050"
        }, 
        "overall_contact_backup": {
            "email": "arubin@forsightv5.com", 
            "last_name": "Anne Rubin", 
            "phone": "650-325-2050"
        }, 
        "overall_official": {
            "affiliation": "ForSight VISION5", 
            "last_name": "Anne Rubin", 
            "role": "Study Director"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": [
                "Latvia: Institutional Review Board", 
                "Latvia: State Agency of Medicines"
            ], 
            "has_dmc": "No"
        }, 
        "phase": "Phase 1", 
        "primary_completion_date": {
            "#text": "March 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Ocular Tonometry (change from baseline)", 
            "safety_issue": "No", 
            "time_frame": "Week 2, 6, 12 and Months 4,5,6"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01943721"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "measure": "Safety as assessed by Slit Lamp Exam", 
            "safety_issue": "Yes", 
            "time_frame": "Weeks 2,6,12 and Months 4,5,6"
        }, 
        "source": "ForSight Vision5, Inc.", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "ForSight Vision5, Inc.", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "October 2013", 
        "study_design": "Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Prevention", 
        "study_type": "Interventional", 
        "verification_date": "December 2013"
    }
}